Get started Log in

PAR — Paradigm Biopharmaceuticals Share News

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall Cap

Market Cap
AU$143.29m
Enterprise Value
AU$135.35m
Revenue
AU$8.12m

Brief: Paradigm Biopharmaceuticals Says FDA Grants Paradigm Fast Track Designation For OA
12/04/2022 08:52
Australia's Paradigm Biopharma surges on FDA fast-track nod for arthritis drug
12/04/2022 03:44
Brief: Paradigm Biopharmaceuticals Initiates Phase 3 Clinical Trial In Knee Osteoarthritis Across The U.S
17/03/2022 17:28
Australia's Paradigm Biopharmaceuticals rises on UK nod for clinical trial
17/03/2022 03:41
Brief: Paradigm Biopharmaceuticals Says Uk Ethics And Regulatory Approval For Phase 3 Study
17/03/2022 01:21
Australia Stock Exchange release from PARADIGM BIOPHAR : UK ethics and regulatory approval for Phase 3 study
16/03/2022 22:20
Australia Stock Exchange release from PARADIGM BIOPHAR : Change in substantial holding
09/03/2022 05:14
Australia Stock Exchange release from PARADIGM BIOPHAR : Change of Director's Interest Notice
09/03/2022 05:14
Australia Stock Exchange release from PARADIGM BIOPHAR : Clarification of recent analyst report on Patent Protection
08/03/2022 23:54
Australia Stock Exchange release from PARADIGM BIOPHAR : PRE_NR Ends: 11:05:34
08/03/2022 23:54
Australia Stock Exchange release from PARADIGM BIOPHAR : S&P DJI Announces March 2022 Quarterly Rebalance
04/03/2022 06:03
Australia Stock Exchange release from PARADIGM BIOPHAR : PRE_NR Ends: 17:13:11
04/03/2022 06:03
Brief: Paradigm Biopharmaceuticals Posts HY Net Loss Attributable A$27 Million
24/02/2022 24:31
Australia Stock Exchange release from PARADIGM BIOPHAR : Amended Appendix 4D
24/02/2022 24:00
Australia Stock Exchange release from PARADIGM BIOPHAR : Paradigm 1HY22 Key Activity Highlights
23/02/2022 23:15
Australia Stock Exchange release from PARADIGM BIOPHAR : PRE_NR Ends: 10:26:05
23/02/2022 23:15
Australia Stock Exchange release from PARADIGM BIOPHAR : Half Yearly Report and Accounts
23/02/2022 22:47
Australia Stock Exchange release from PARADIGM BIOPHAR : PRE_NR Ends: 09:58:20
23/02/2022 22:47
Australia Stock Exchange release from PARADIGM BIOPHAR : PPS a new adjunct therapy treatment for patients with MPS VI
10/02/2022 23:04
Australia Stock Exchange release from PARADIGM BIOPHAR : Change of Director's Interest Notice
01/02/2022 05:11